NCT00774241 2016-11-02PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast CancerHoffmann-La RochePhase 4 Withdrawn
NCT01156961 2016-11-02A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)Hoffmann-La RochePhase 4 Withdrawn